Free tool
Stocks listed on Stockholm
We cover 158 companies listed on Stockholm. The median market value in the group is $19.97M. Across the group, the median move over the past trading day is +0.31%. 45% of the 157 with a 200-day average trade above it. Price change over the past year runs from −76.0% to +38.8% across the middle 80 percent of the group, with a median of −24.1%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
158 of 928 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| ALVO-SDB.ST | Alvotech | $1.74B | Small cap | −39.57% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% |
| VICO.ST | Vicore Pharma Holding AB (publ) | $315.07M | Small cap | −1.29% |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% |
| STIL.ST | Stille AB | $216.03M | Small cap | −4.26% |
| CARA.ST | Carasent AB (publ) | $178.28M | Small cap | −10.62% |
| FLERIE.ST | Flerie AB (publ) | $172.03M | Small cap | −48.05% |
| SANION.ST | Saniona AB (publ) | $171.29M | Small cap | −12.37% |
| BINV.ST | BioInvent International AB (publ) | $162.35M | Small cap | −23.46% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $148.23M | Small cap | −53.59% |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% |
| GENO.ST | Genovis AB (publ.) | $146.60M | Small cap | −16.91% |
| PAX.ST | Paxman AB (publ) | $139.52M | Small cap | −21.45% |
| SEDANA.ST | Sedana Medical AB (publ) | $132.45M | Small cap | −22.05% |
| MVIR.ST | Medivir AB (publ) | $131.70M | Small cap | +4.73% |
| CRAD-B.ST | C-Rad AB (publ) | $122.23M | Small cap | +6.49% |
| HAMLET-B.ST | Hamlet BioPharma AB (publ) | $121.98M | Small cap | −0.81% |
| SYNACT.ST | SynAct Pharma AB | $111.82M | Small cap | +10.82% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | $91.93M | Micro cap | +15.88% |
| NANEXA.ST | Nanexa AB (publ) | $87.59M | Micro cap | +100.43% |
| EQL.ST | EQL Pharma AB (publ) | $87.58M | Micro cap | −67.01% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $86.56M | Micro cap | +78.27% |
| DICOT.ST | Dicot Pharma AB | $78.22M | Micro cap | −76.06% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | $68.21M | Micro cap | −11.27% |
| ONCO.ST | Oncopeptides AB (publ) | $68.14M | Micro cap | −67.92% |
| SEZI.ST | Senzime AB (publ) | $61.48M | Micro cap | −39.98% |
| EPIS-B.ST | Episurf Medical AB (publ) | $53.85M | Micro cap | +71.52% |
| MOB.ST | Moberg Pharma AB (publ) | $53.40M | Micro cap | +32.92% |
| FLUO.ST | FluoGuide A/S | $53.21M | Micro cap | −18.34% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $52.93M | Micro cap | −46.25% |
| XSPRAY.ST | Xspray Pharma AB (publ) | $51.97M | Micro cap | −76.00% |
| CANTA.ST | Cantargia AB (publ) | $51.16M | Micro cap | −27.38% |
| ORX.ST | Orexo AB (publ) | $48.90M | Micro cap | −35.06% |
| IMMU.ST | Mendus AB (publ) | $46.19M | Micro cap | −4.57% |
| CLBIO.ST | Corline Biomedical AB | $45.27M | Micro cap | +45.56% |
| OSSD.ST | OssDsign AB (publ) | $44.89M | Micro cap | −73.26% |
| ENZY.ST | Enzymatica AB (publ) | $44.85M | Micro cap | −20.17% |
| MNTC.ST | Mentice AB (publ) | $40.01M | Micro cap | −6.59% |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% |
| ORT-B.ST | Ortoma AB (publ) | $37.82M | Micro cap | −66.52% |
| QLINEA.ST | Q-linea AB (publ) | $36.80M | Micro cap | −62.97% |
| SPRINT.ST | Sprint Bioscience AB (publ) | $35.56M | Micro cap | +458.51% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | $35.21M | Micro cap | +4.75% |
| BRAIN.ST | BrainCool AB (publ) | $32.34M | Micro cap | −21.51% |
| ACARIX.ST | Acarix AB (publ) | $32.23M | Micro cap | −14.11% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $27.48M | Micro cap | −44.31% |
| ISOFOL.ST | Isofol Medical AB (publ) | $26.92M | Micro cap | −1.87% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | $26.60M | Micro cap | +97.38% |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% |
| SCIB.ST | SciBase Holding AB (publ) | $21.47M | Micro cap | −29.25% |
| DEX.ST | Dextech Medical AB | $20.09M | Micro cap | +26.38% |
| XBRANE.ST | Xbrane Biopharma AB (publ) | $19.86M | Micro cap | −72.31% |
| ORTI-A.ST | Ortivus AB (publ) | $18.61M | Micro cap | −35.48% |
| ELIC.ST | Elicera Therapeutics AB (publ) | $18.53M | Micro cap | −61.50% |
| ALZ.ST | Alzinova AB (publ) | $17.74M | Micro cap | −39.02% |
| ABERA.ST | Abera Bioscience AB | $17.69M | Micro cap | +1.61% |
| SENZA.ST | SenzaGen AB | $17.61M | Micro cap | −17.48% |
| INIT.ST | Initiator Pharma A/S | $17.46M | Micro cap | −27.35% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | $17.00M | Micro cap | +3.31% |
| DMYD-B.ST | Diamyd Medical AB (publ) | $16.69M | Micro cap | −90.97% |
| PRO.ST | Promimic AB (publ) | $16.46M | Micro cap | −41.38% |
| XINT.ST | Xintela AB (publ) | $16.41M | Micro cap | −51.08% |
| ORTI-B.ST | Ortivus AB (publ) | $15.21M | Micro cap | +42.11% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| NICA.ST | Nanologica AB (publ) | $13.84M | Micro cap | −69.86% |
| PTRK.ST | Physitrack PLC | $13.83M | Micro cap | −57.58% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.67M | Micro cap | −30.12% |
| IZAFE-B.ST | iZafe Group AB (publ) | $13.66M | Micro cap | −17.57% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | $13.60M | Micro cap | −28.35% |
| ACUC.ST | AcuCort AB (publ) | $13.44M | Micro cap | −5.94% |
| NOSA.ST | Nosa Plugs AB | $13.38M | Micro cap | −35.62% |
| BOUL.ST | Boule Diagnostics AB (publ) | $12.76M | Micro cap | −47.36% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| NXTCL.ST | NextCell Pharma AB | $12.42M | Micro cap | −5.10% |
| ARCOMA.ST | Arcoma AB | $12.17M | Micro cap | −2.13% |
| VIVE.ST | Vivesto AB | $10.39M | Micro cap | −57.13% |
| ONCOZ.ST | OncoZenge AB (publ) | $10.32M | Micro cap | −14.59% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | $10.27M | Micro cap | −46.03% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | $10.10M | Micro cap | −19.74% |
| IMMNOV.ST | Immunovia AB (publ) | $10.07M | Micro cap | −70.74% |
| BIBB.ST | BiBBInstruments AB | $9.70M | Micro cap | −84.94% |
| IDLDX.ST | IDL Diagnostics AB (publ) | $9.63M | Micro cap | −2.36% |
| SPAGO.ST | Spago Nanomedical AB (publ) | $9.60M | Micro cap | −54.00% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | $9.27M | Micro cap | −75.86% |
| ACE.ST | Ascelia Pharma AB (publ) | $8.78M | Micro cap | −88.08% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | $8.30M | Micro cap | −0.39% |
| PILA.ST | Pila Pharma AB (publ) | $7.79M | Micro cap | −15.41% |
| ERMA.ST | Enorama Pharma AB (publ) | $7.06M | Micro cap | −67.04% |
| CHOSA.ST | Chosa Oncology AB | $7.01M | Micro cap | −9.00% |
| SYNT.ST | SyntheticMR AB (publ) | $6.88M | Micro cap | −74.29% |
| ACOU.ST | AcouSort AB (publ) | $6.64M | Micro cap | −18.29% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | $6.35M | Micro cap | −85.49% |
| PEXA-B.ST | PExA AB (publ) | $6.18M | Micro cap | +79.47% |
| QLIFE.ST | Qlife Holding AB (publ) | $5.65M | Micro cap | −52.47% |
| NEOLA.ST | Neola Medical AB (publ) | $5.57M | Micro cap | −79.24% |
| REDS.ST | Redsense Medical AB (publ) | $5.52M | Micro cap | −39.96% |
| BIOSGN.ST | Biosergen AB (publ) | $5.31M | Micro cap | −94.62% |
| ODI.ST | ODI Pharma AB (publ) | $5.24M | Micro cap | +39.24% |
| SDOS.ST | ScandiDos AB (publ) | $5.24M | Micro cap | −34.85% |
| SERV.ST | Servana AB | $5.18M | Micro cap | +106.67% |
| FLUI.ST | Fluicell AB (publ) | $5.06M | Micro cap | +247.74% |
| KONT.ST | Kontigo Care AB (publ) | $4.68M | Micro cap | −42.39% |
| AINO.ST | Aino Health AB (publ) | $4.25M | Micro cap | −10.81% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $3.53M | Micro cap | +11.79% |
| PMED.ST | PEPTONIC medical AB (publ) | $3.47M | Micro cap | −25.00% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | $3.19M | Micro cap | −93.99% |
| SPERM.ST | Spermosens AB (publ) | $3.13M | Micro cap | +15.79% |
| GUARD.ST | Disruptive Pharma AB (publ) | $3.11M | Micro cap | −93.53% |
| PROGEN.ST | Prostatype Genomics AB (publ) | $2.80M | Micro cap | −79.42% |
| PERP-B.ST | Perpetua Medical AB (publ) | $2.73M | Micro cap | −35.32% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | $2.61M | Micro cap | −59.79% |
| SPEC.ST | SpectraCure AB (publ) | $2.56M | Micro cap | −81.77% |
| POLAR.ST | PolarCool AB (publ) | $2.23M | Micro cap | −67.96% |
| GABA.ST | Gabather AB (publ) | $2.23M | Micro cap | −17.20% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | $2.22M | Micro cap | −58.08% |
| PHAL.ST | PharmaLundensis AB | $2.14M | Micro cap | +37.83% |
| RESP.ST | Respiratorius AB (publ) | $1.89M | Micro cap | −39.20% |
| ATORX.ST | Alligator Bioscience AB (publ) | $1.88M | Micro cap | −99.27% |
| IMS.ST | Invent Medic Sweden AB (publ) | $1.81M | Micro cap | −22.48% |
| APTA.ST | Aptahem AB (publ) | $1.50M | Micro cap | −67.65% |
| MONI.ST | Monivent AB | $1.48M | Micro cap | −37.02% |
| NANECH.ST | NanoEcho AB (publ) | $1.42M | Micro cap | −72.03% |
| 2CUREX.ST | 2cureX AB (publ) | $1.34M | Micro cap | −71.79% |
| ODIN.ST | Odinwell AB (publ) | $1.21M | Micro cap | −61.25% |
| LXB.ST | Luxbright AB (publ) | $976.04K | Micro cap | −91.76% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | $966.89K | Micro cap | −98.15% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | $765.95K | Micro cap | −73.58% |
| S2M.ST | S2Medical AB (publ) | $550.90K | Micro cap | −63.08% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | $506.85K | Micro cap | −72.69% |
| SDET.ST | SensoDetect Aktiebolag (publ) | $148.56K | Micro cap | −99.53% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.